Bone mineral densitometry in patients on hemodialysis: Difference between genders and what to measure

Renal Failure

Volumn 32, Issue 3, 2010, Pages 300-308

  Orlic, Lidija ^a   Crncevic, Zeljka ^a   Pavlovic, Drasko ^b   Zaputovic, Luka ^a  

^a KBC RIJEKA   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Bone mineral density; Chronic kidney disease; Dual X ray absorptiometry; Hemodialysis; Osteoporosis

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BONE DENSITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FEMUR NECK; FOREARM; GROUPS BY AGE; HEMODIALYSIS PATIENT; HUMAN; LABORATORY TEST; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NECK; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE; TREATMENT DURATION;

ABSORPTIOMETRY, PHOTON; ALKALINE PHOSPHATASE; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; CHRONIC DISEASE; FEMALE; FOREARM; HIP; HUMANS; KIDNEY DISEASES; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; PHOSPHORUS; RENAL DIALYSIS; SEX CHARACTERISTICS;

EID: 77950558278     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860221003611661     Document Type: Article

References (21)

1. Stehman-Breen C. Osteoporosis and chronic kidney disease. Semin Nephrol. 2004;24:78-81
2. Gal-Moscovici A, Sprague SM. Osteoporosis and chronic kidney disease. Semin Dial. 2007;20:423-430.
3. Levis S, Altman R. Bone densitometry: Clinical consideration. Arthritis Rheum. 1998;41:577-578.
4. Baim S, Binkley N, Bilezikian JP, et al. Official positions of the international society for clinical densitometry end executive summary of the 2007 ISCD position development conference. J Clin Densitom. 2008;11:75-91. (Pubitemid 351602189)
5. Adams J, Bishop N. DXA in adults and children. In: Rosen JE, ed. Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. Washington, DC: American Society for Bone and Mineral Research; 2008:152-158.
6. Elder G. Pathophysiology and recent advances in the management of renal osteodystrophy. J Bone Miner Res. 2002;17:2094-2105.
7. KDOQI, National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(3):1-201.
8. Martin KJ, Olgaard K, Coburn JW, et al. Diagnosis, assessment and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis. 2004;43:558-565.
9. Hruska KA, Mathew S. Chronic kidney disease mineral bone disorder (CKD-MBD). In: Rosen JE, ed. Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. Washington, DC: American Society for Bone and Mineral Research; 2008:343-349.
10. Cunningham J, Sprague SM, Cannata-Andia J, et al. Osteoporosis in chronic kidney disease. Am J Kidney Dis. 2004;43:566-571.
11. Grampp S, Genant HK, Mathur A, et al. Comparison of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res. 1997;12:697-711.
12. Ersoy FF. Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol. 2007;39:321-331.
13. Pavlovic D, Tomic Brzac H. Prevention and treatment of secondary hyperparathyroidism: Still a challenge for the nephrologist? Nephrol Dial Transplant. 2003;18(5):45-46.
14. Lindberg JS, Moe MS. Osteoporosis in end-stage renal disease. Semin Nephrol. 1999;19:115-122.
15. Kanenko TM, Foley RN, Gilbertson DT, Collins AJ. Clinical epidemiology of long-bone fractures in patients receiving hemodialysis. Clin Orthop Relat Res. 2007;457:188-193.
16. Negri AL, Barone R, Quiroga MA, et al. Bone mineral density: Serum markers of bone turnover and their relationships in peritoneal dialysis. Perit Dial Int. 2004;24:163-168.
17. Ersoy FF, Passadakis SP, Tam P, et al. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis. J Bone Miner Metab. 2006;24:79-86.
18. Urena P, Bernard-Poenaru O, Ostertag A, et al. Bone mineral density, biochemical markers and skeletal fractures in hemodialysis patients. Nephrol Dial Transplant. 2003;18:2325-2331.
19. Leinau L, Perazella MA. Hip fractures in end-stage renal disease patients: Incidence, risk factors and prevention. Semin Dial. 2006;19:75-79.
20. Doumouchtsis KK, Kostakis AI, Doumouchtsis SK, et al. Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients. J Bone Miner Metab. 2008;26:66-72.
21. Bacchetta J, Boutroy S, Jillrad L, et al. Bone imaging and chronic kidney disease: Will high-resolution peripheral tomography improve bone evaluation and therapeutic management? J Ren Nutr. 2009;19:44-49.